title: Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival.
abstract: Racial and ethnic minority patients continue to die disproportionately from breast cancer compared with their white counterparts, even after adjusting for insurance status and income. No studies have examined whether surveillance mammography reduces racial disparities in survival among elderly breast cancer survivors following active treatment for breast cancer. This study included 28,117 cases diagnosed with primary breast cancer at age 66 years and over, identified from SEER data during 1992-2005. Kaplan-Meier methods and Cox regression models were used for survival analysis. A higher proportion of whites received surveillance mammograms during the surveillance period compared with nonwhites: 71.7% of African-Americans, 72.5% of Hispanics, and 69.3% of Asians had mammograms compared with 74.9% of whites. In propensity-score-adjusted analysis, women who had a mammogram within 2 years were less likely (hazard ratio 0.84; 95% CI 0.78-0.82) to die from any cause compared with women who did not have any mammograms during this time period. The hazard ratio of cancer-specific mortality elevated for Hispanics compared with whites (hazard ratio 1.5; 95% CI 0.6-3.2) and was reduced after adjusting for surveillance mammography (hazard ratio 1.4; 95% CI 0.5-2.9). Similar pattern in the reduction in disease-specific hazard ratio was observed for blacks: After controlling for patient and tumor characteristics, hazard ratio was elevated but not significantly different from that in whites (hazard ratio 2.0; 95% CI 0.9-3.7), and hazard ratio adjusting for surveillance mammography further reduced the point estimate (hazard ratio 1.5; 95% CI 0.7-2.8). Asian and Pacific Islanders and Hispanics appeared to have lower risks of all-cause mortality compared with whites after controlling for patient and tumor characteristics and surveillance mammogram received. Our findings indicates that while surveillance mammograms and physician visits may play a contributory role in achieving equal outcomes for breast cancer-specific mortality for women with breast cancer, searching for other factors that might help achieve national goals to eliminate racial disparities in healthcare, and outcomes is warranted.
authors: Divisions of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center, Houston, TX, USA, znurgalieva@mdanderson.org.
authors: Z Z
authors: ZZ
authors: Nurgalieva
authors: L
authors: L
authors: Franzini
authors: R
authors: R
authors: Morgan
authors: S W
authors: SW
authors: Vernon
authors: C C
authors: CC
authors: Liu
authors: X L
authors: XL
authors: Du
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D005006:Ethnicity; D005260:Female; D054625:Healthcare Disparities; D006801:Humans; D008327:Mammography / Q000379:methods; D009026:Mortality; D062486:Public Health Surveillance / Q000379:methods; D018426:SEER Program; D012959:Socioeconomic Factors; D016019:Survival Analysis
references: Ann Intern Med. 1997 Oct 15;127(8 Pt 2):757-63
references: 9382394
references: Ann Intern Med. 2002 Nov 19;137(10):783-90
references: 12435214
references: J Clin Epidemiol. 1992 Jun;45(6):613-9
references: 1607900
references: AJR Am J Roentgenol. 1995 Dec;165(6):1373-7
references: 7484568
references: Med Care. 2001 Sep;39(9):945-55
references: 11502952
references: Arch Fam Med. 1999 Nov-Dec;8(6):487-91
references: 10575386
references: Breast Cancer Res Treat. 2009 Mar;114(1):169-78
references: 18368477
references: Cancer. 2001 Aug 15;92(4):730-7
references: 11550141
references: Med Care. 2000 Mar;38(3):281-9
references: 10718353
references: Ethn Dis. 2010 Spring;20(2):155-61
references: 20503896
references: Med Care. 2002 Aug;40(8 Suppl):IV-55-61
references: 12187169
references: Eval Program Plann. 2011 May;34(2):97-104
references: 20810168
references: Am J Epidemiol. 2006 Jun 15;163(12):1149-56
references: 16624967
references: Med Care. 2002 Aug;40(8 Suppl):IV-3-18
references: 12187163
references: Oncologist. 2012;17(8):1027-31
references: 22752069
references: Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):841-53
references: 15386709
references: J Chronic Dis. 1987;40(5):373-83
references: 3558716
references: Health Serv Res. 2002 Dec;37(6):1643-57
references: 12546290
references: J Clin Epidemiol. 2000 Dec;53(12):1258-67
references: 11146273
references: J Clin Oncol. 2006 Jan 1;24(1):85-94
references: 16382117
references: Breast Cancer Res Treat. 2008 Oct;111(3):489-96
references: 17957465
references: JAMA. 1992 Nov 4;268(17):2388-94
references: 1404795
references: Breast Cancer Res Treat. 2004 Jan;83(1):25-32
references: 14997052
references: J Clin Oncol. 2003 Apr 15;21(8):1447-51
references: 12697865
references: Med Care. 2007 Jan;45(1):66-72
references: 17279022
references: Ann Epidemiol. 1998 Oct;8(7):439-44
references: 9738690
references: Med Care. 2002 Aug;40(8 Suppl):IV-69-74
references: 12187171
references: N Engl J Med. 1995 Apr 27;332(17):1138-43
references: 7700288
references: Cancer. 2011 Aug;117(15 Suppl):3539-42
references: 21780088
references: Med Care. 1998 Jun;36(6):804-17
references: 9630122
references: PLoS Med. 2006 Jul;3(7):e193
references: 16805649
references: J Gen Intern Med. 2008 Feb;23(2):158-63
references: 18060463
references: J Clin Oncol. 1999 Mar;17(3):1080-2
references: 10071303